Delivery Order SPE2DB20D1100-SPE2DB25FD6X6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) with a ceiling value of $2,030.22. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is listed as Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is...
- The Defense Logistics Agency awarded a $1,452.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical will be delivered to...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules in a quantity of 100 units, with a ceiling value of $2,008.80. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 4, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,389.74 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 20 mg capsules (100-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and has an ultimate completion date of July 24, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2.71K to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,468.50 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 25 mg capsules (100-count units). This firm fixed price, non-set-aside delivery order was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,047.40 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 5 mg capsules (100-count units) on July 30, 2025. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by July 31, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical supply transaction under the company's larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,211.15 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) under a firm fixed price contract type. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside competitive procurement. The product will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100, valued at $1,242.74. This is a firm fixed price delivery order with an ultimate completion date of July 23, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6X6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) with a ceiling value of $1,199.46. This firm fixed-price delivery order, which is set to be completed by July 30, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $1 billion pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, was competitively selected for this delivery order without set-aside designation. The company holds a significant position as a critical federal medical procurement vendor, serving military and veteran healthcare systems through DLA's Medical Supply Chain. This delivery order exemplifies the company's role in supporting military medical readiness through the supply of controlled pharmaceutical products as part of its broader federal contract portfolio with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/29/25 |